Philippines - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingPhilippines: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024
Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the Philippines
The Philippine prophylactic medicaments containing insulin market soared to $X in 2023, growing by X% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). In general, consumption recorded a buoyant expansion. Prophylactic medicaments containing insulin consumption peaked in 2023 and is expected to retain growth in the near future.
Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses
Exports from the Philippines
In 2023, exports of medicaments containing insulin but not antibiotics in measured doses from the Philippines surged to X kg, growing by X% on the year before. Over the period under review, exports, however, showed a abrupt setback. The pace of growth was the most pronounced in 2020 with an increase of X%. Over the period under review, the exports reached the peak figure at X kg in 2021; however, from 2022 to 2023, the exports stood at a somewhat lower figure.
In value terms, prophylactic medicaments containing insulin exports stood at $X in 2023. Overall, exports, however, showed a deep contraction. The pace of growth appeared the most rapid in 2020 when exports increased by X%. The exports peaked at $X in 2015; however, from 2016 to 2023, the exports failed to regain momentum.
Exports by Country
Barbados (X kg) and Canada (X kg) were the main destinations of prophylactic medicaments containing insulin exports from the Philippines. Moreover, prophylactic medicaments containing insulin exports in Barbados exceeded the figures recorded by the second-largest exporter, Canada, twofold.
From 2012 to 2023, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Barbados (with a CAGR of X%).
In value terms, Barbados ($X) and Canada ($X) were the largest markets for prophylactic medicaments containing insulin exported from the Philippines worldwide.
Canada, with a CAGR of X%, recorded the highest growth rate of the value of exports, among the main countries of destination over the period under review.
Export Prices by Country
The average prophylactic medicaments containing insulin export price stood at $X per ton in 2023, dropping by X% against the previous year. Over the period under review, the export price continues to indicate a deep setback. The pace of growth appeared the most rapid in 2022 when the average export price increased by X% against the previous year. Over the period under review, the average export prices reached the peak figure at $X per ton in 2018; however, from 2019 to 2023, the export prices stood at a somewhat lower figure.
Average prices varied noticeably for the major overseas markets. In 2023, amid the top suppliers, the country with the highest price was Canada ($X per ton), while the average price for exports to Barbados totaled $X per ton.
From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to Canada (X%).
Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses
Imports into the Philippines
In 2023, purchases abroad of medicaments containing insulin but not antibiotics in measured doses increased by X% to X tons, rising for the second year in a row after two years of decline. In general, imports continue to indicate resilient growth. The pace of growth appeared the most rapid in 2016 when imports increased by X%. Imports peaked at X tons in 2019; however, from 2020 to 2023, imports remained at a lower figure.
In value terms, prophylactic medicaments containing insulin imports skyrocketed to $X in 2023. Over the period under review, imports saw a resilient expansion. The pace of growth was the most pronounced in 2014 when imports increased by X%. Over the period under review, imports hit record highs in 2023 and are expected to retain growth in the near future.
Imports by Country
Denmark (X tons), Germany (X tons) and India (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to the Philippines, together accounting for X% of total imports. Brazil, Pakistan, France, Italy, Poland and the United States lagged somewhat behind, together accounting for a further X%.
From 2012 to 2023, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Brazil (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.
In value terms, Denmark ($X), Germany ($X) and Pakistan ($X) constituted the largest prophylactic medicaments containing insulin suppliers to the Philippines, together comprising X% of total imports. Brazil, France, India, Italy, the United States and Poland lagged somewhat behind, together comprising a further X%.
India, with a CAGR of X%, saw the highest growth rate of the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.
Import Prices by Country
In 2023, the average prophylactic medicaments containing insulin import price amounted to $X per ton, increasing by X% against the previous year. In general, the import price continues to indicate a relatively flat trend pattern. The pace of growth appeared the most rapid in 2014 when the average import price increased by X% against the previous year. As a result, import price attained the peak level of $X per ton. From 2015 to 2023, the average import prices remained at a lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2023, amid the top importers, the country with the highest price was the United States ($X per ton), while the price for India ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Pakistan (X%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the Philippines. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale
Country coverage:
- Philippines
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in the Philippines
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Asia.
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the U.S..
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in China.
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the EU.
This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin.
- Market Research in the Philippines
- Price for Prophylactic Medicaments Containing Insulin the Philippines
- Prophylactic Medicaments Containing Insulin Market
- Hormones Market
- Glycosides and Vegetable Alkaloids Market
- Antibiotic Market
- Organ Extracts Market
- Antisera Market
- Biological Product Market
- Sterile Medical Adhesion Barrier Market